Drug intelligence / Profile preview

Cesra

Development stage: Preclinical
Lead developer: Cesra
Modality: Small Molecules

Overview

Cesra is a phytopharmaceutical drug produced by Cesra Arzneimittel GmbH & Co. KG, a German company founded in 1929 that specializes in plant-based medicines and medical cosmetics. While the company produces a range of phytopharmaceuticals, specific details regarding the active ingredients and precise mechanism of action for a drug explicitly named "Cesra" are not publicly detailed. It is being investigated in a clinical trial for breast cancer-related lymphedema.

Brand names: Cesra

Beyond the preview

Go deeper on Cesra.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cesra.

Explore the full profile